Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Senator seeks deadline for Medicare to prevent prescription drug fraud

By Joe Eaton

Taxpayer-funded Medicare recently spent more than $1 billion on drug prescriptions missing a valid doctor identification number and a Senate

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system
Advertisement

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Excerpts from this story referencing "Prescription Drug":

"… ulatory power to the Food and Drug Administration and revisit the Medicare Prescription Drug, Improvement, and Modernization Act, a law that came into being in 2003 af …"

"… try had better luck with two other laws it lobbied robustly to extend, the Prescription Drug User Fee Act and the Best Pharmaceuticals for Children Act. Both were reau …"

"… eutical industry's powerful lobby. The law he introduced, the Fair Balance Prescription Drug Advertisement Act of 2007, never came out of committee. The industry argue …"

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Excerpts from this story referencing "Prescription Drug":

"… drew heavy drug industry lobbying was to undo a provision of the Medicare Prescription Drug, Improvement and Modernization Act of 2003. The legislation, which was pas …"

"… t the same fate.This session, the new Democratic House passed the Medicare Prescription Drug Price Negotiation Act, which requires price negotiation, and the Senate is …"

States see importation as solution to high drug costs

By Victoria Kreha

Several seek, have plans despite federal and industry opposition